Denali Therapeutics, Inc. (DNLI)
24.20
-0.72
(-2.89%)
USD |
NASDAQ |
Aug 24, 16:00
23.73
-0.47
(-1.94%)
After-Hours: 20:00
Denali Therapeutics Gross Profit Margin (Quarterly) : -52.39% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -52.39% |
| March 31, 2026 | |
| December 31, 2025 | |
| September 30, 2025 | |
| June 30, 2025 | |
| March 31, 2025 | |
| December 31, 2024 | |
| September 30, 2024 | |
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 | |
| September 30, 2023 | -74.98% |
| June 30, 2023 | 99.54% |
| March 31, 2023 | 73.91% |
| December 31, 2022 | 68.61% |
| September 30, 2022 | 64.15% |
| June 30, 2022 | 97.65% |
| Date | Value |
|---|---|
| March 31, 2022 | 96.92% |
| December 31, 2021 | 89.52% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
| March 31, 2020 | 0.00% |
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
| June 30, 2019 | 0.00% |
| March 31, 2019 | 0.00% |
| December 31, 2018 | 98.11% |
| September 30, 2018 | -94.73% |
| June 30, 2018 | 9.16% |
| March 31, 2018 | -33.23% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 91.15% |
| Biogen, Inc. | 61.37% |
| Oncolytics Biotech, Inc. | -- |
| Sangamo Therapeutics, Inc. | 39.18% |
| Sarepta Therapeutics, Inc. | 60.18% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -54.08% |
| Return on Assets | -44.16% |
| Return on Invested Capital | -51.77% |
| Profit Margin (Quarterly) | -3.54K% |
| Operating Margin (Quarterly) | -3.62K% |
| Return on Net Operating Assets | -360.5% |